![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-281.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7189&fp-y=0.3267&dm=1705442268&s=ec7b5a63f24d02abcda9230550f04386)
CEO Chats, Flagship@JPM2024
Filter by Topic:
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-281.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7189&fp-y=0.3267&dm=1705442268&s=ec7b5a63f24d02abcda9230550f04386)
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-299.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5921&fp-y=0.2958&dm=1704998947&s=92f9772306d2a41cc49326768d76a884)
2024 CEO Chat: John Lepore, ProFound™ Therapeutics
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-293.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&dm=1704998528&s=4ec20241a9a4df27d0760bfdc57bd988)
2024 CEO Chat: Mike Nally, Generate:Biomedicines
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-288-1.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5897&fp-y=0.3919&dm=1705442586&s=70c481252319bd690a7a1a02421920f2)
2024 CEO Chat: Steve Harr, Sana Biotechnology
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-223_under-2.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5&fp-y=0.3778&dm=1704922325&s=bedb28522de63749aeb92e7cabfc14bf)
2024 CEO Chat: Guillaume Pfefer, Sail Biomedicines
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-215.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.6708&fp-y=0.3757&dm=1704922202&s=88b2d9f853a4c51712870b5288cf6482)
2024 CEO Chat: Volker Herrmann, Sonata Therapeutics
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Lovisa-Metaphore.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.8193&fp-y=0.4402&dm=1704901443&s=76aa3801c11b52eaaae963a82d9868a5)
2024 CEO Chat: Lovisa Afzelius, Metaphore Biotechnologies
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Jason-G-Ampersand.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7916&fp-y=0.3044&dm=1704901403&s=4d09d3c4be6dcb7b93cf612d525101c8)